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Objective: The purpose of this study was to determine the relationship between aneurysm sac size change at 1, 6, 12, and
24 months and a set of 10 independent “predictive” variables by using a general linear model analysis.
Methods: In a multicenter trial, 351 patients received the Zenith tri-modular bifurcated endograft. The predictive variables
used for this analysis were endoleak by type, age, gender, smoking status, and the preprocedure variables of maximum
aneurysm major diameter, minor neck diameter, proximal neck length, neck plaque/thrombus, and neck shape; and
patent inferior mesenteric artery at predischarge. The aneurysm change was calculated as the difference from the
predischarge (<7 days of implant) maximum aneurysm major diameter measurement to the maximum aneurysm major
diameter measurement at follow-up examination periods of 1, 6, 12, and 24 months. The same 10 predictive variables
were used to assess the absolute change in maximum aneurysm minor diameter and aneurysm area. Additionally, the
percent change from predischarge was also assessed for the major diameter, minor diameter, and aneurysm area.
Results: None of the independent variables were predictive of absolute sac size change or percent change at 1 month. At 6
months, the presence of an endoleak (P< .01) and preprocedure neck thrombus/plaque (P .01) were significant predictors
of absolute and relative aneurysm size change for all measurements (major diameter, minor diameter, and area) and were more
likely to be associated with less sac shrinkage or to have sac growth. Additionally, preoperative maximum aneurysm major
diameter was a significant predictor for absolute change in area (P< .01). Larger preprocedure aneurysm diameters were more
likely to experience more shrinkage. The significant predictors of size change at 12 months included preprocedure maximum
aneurysm major diameter, the presence of endoleak at 12 months, preoperative neck thrombus/plaque, and gender. At 24
months, significant predictors of aneurysm size change included preprocedure maximum aneurysm major diameter, endoleak
at 24 months, and preprocedure neck thrombus/plaque. When the longitudinal model was used, the presence of an endoleak,
thrombus/plaque within the proximal neck at preprocedure, and preprocedure maximum aneurysm major diameter were
found to be significantly related to the size of the maximum aneurysm major diameter over time.
Conclusions: This study supports the concept that early and late sac size change following EVAR is influenced by
identifiable independent predictive variables. ( J Vasc Surg 2006;43:649-56.)Although the goal of endovascular aneurysm repair
(EVAR) is prevention of aneurysm-related death, many au-
thors have focused on other outcome measures in an attempt
to identify variables that might be predictive of success. There
is widespread agreement that persistent type I and III en-
doleaks result in continued pressurization of the aneurysm sac,
but the significance and management of type II endoleaks
remains a subject of some controversy.
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doi:10.1016/j.jvs.2005.11.042Aneurysm sac shrinkage has been viewed as a favorable
outcome measure following EVAR,1,2 implying that the an-
eurysm sac has been successfully depressurized,3 whereas sac
enlargement certainly has an ominous connotation given the
known association of aneurysm sac size and the risk of rupture.
Furthermore, although the rate of decrease in aneurysm size
after EVAR may approximate the reported expansion rate in
untreated aneurysms, individual aneurysm behavior is unpre-
dictable.4
In addition, it has been demonstrated that the initial
presence of an endoleak following EVAR is not predictive of
the lack of sac regression.5 A number of reports have sug-
gested that aneurysm sac shrinkage after EVAR is a device-
dependent phenomenon, with some endograft designs dem-
onstrating more pronounced reductions in the size of the
aneurysm sac over time.6,7 Other studies have suggested that
ruptured aneurysms treatedwith EVARexperience sac regres-
sion at a higher rate than do electively treated aneurysms. 8 It is
likely that other independent anatomic or physiologic vari-
ables may influence the behavior of the aneurysm sac follow-
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relationship between aneurysm sac size change at 1, 6, 12, or
24 months and a set of 10 independent “predictive” variables
by using a general linear model analysis.
MATERIALS AND METHODS
This study is a retrospective analysis of data collected
during the prospective, multicenter Zenith AAA Endovascu-
lar Graft Clinical Study, which was designed to establish the
safety and effectiveness of the device. Early and intermediate-
term results from this clinical study have been previously
published.10,11 Briefly, 351 patients received the Zenith AAA
Endovascular Graft (Cook, Inc, Bloomington, Ind) at 15
centers throughout the United States. The principal investi-
gators and their respective sites are listed in Table I.
A computed tomography (CT) scan was required pre-
operatively and postdevice implant at predischarge (7
days) and at 1, 6, 12, and 24 months. All CT scan measure-
ments and endoleak assessments were from the Cleveland
Clinic Foundation Angiographic Core Laboratory (Cleve-
land, Ohio). All CT scans were digitally analyzed on a
Macintosh computer (Apple Computer, Inc, Cupertino,
Calif) by using the public domain National Institutes of
Health Image program available on the Internet at http://
rsb.info.nih.gov/nih-image/.
In the analysis process, the table position of the maxi-
Table I. List of participating investigators and
corresponding institutions in the Zenith AAA
Endovascular Graft Clinical Study
Investigator Institution
National Primary Investigator
Roy K. Greenberg, MD Cleveland Clinic Foundation
Timothy A. Chuter, MD University of California, San
Francisco
Site Principal Investigators
Daniel Clair, MD Cleveland Clinic Foundation
Sunita Srivastava, MD
Frederick S. Keller, MD Dotter Interventional
Institute
Stephen G. Lalka, MD Indiana University Medical
Center
Richard P. Cambria, MD Massachusetts General
Hospital
Albert G. Hakaim, MD Mayo Clinic
Frank J. Veith, MD Montefiore Medical Center
W. C. Sternbergh III, MD Ochsner Clinic
Barry S. George, MD MidWest Cardiology
Research Foundation
Richard M. Green, MD Strong Memorial Hospital
Linda M. Reilly, MD University of California, San
Francisco
Ronald M. Fairman, MD University of Pennsylvania
Medical Center
Mark Sarfati, MD University of Utah/Veterans
Administration Hospital
Frank J. Miller, Jr, MD
Frank J. Criado, MD Union Memorial Hospital
David J. Porter, MD Methodist Hospital
Luis Sanchez, MD Washington Universitymum aneurysm diameter was selected. The maximum an-eurysm diameter was the table position indicating the CT
slice with the largest diameter of the aneurysm measured
outer wall to outer wall. From that CT image, perpendic-
ular lines were used to determine the major and minor
diameters. The area of that particular CT slice was also
calculated. A spatial calibration was performed with the use
of a set scale so that results from length and area measure-
ments were presented in calibrated units, such as millime-
ters. Before the scale was set, the line selection tool was
used to make a straight-line selection that corresponded to
a known distance. Images were calibrated by using the scale
included on the CT image. Next, the freehand selection
tool was used to trace the outer wall of the vessel, and
measurements were calculated. The area of selection in
pixels was quantified in calibrated units, such as square
millimeters. The lengths of the major and minor axes of the
best fitting ellipse were calculated by traversing the geomet-
ric center of the region. Aneurysm size change (absolute
and relative) of maximum aneurysmmajor diameter, minor
diameter, and area were calculated. Absolute change in
aneurysm size was calculated as the follow-up aneurysm
measurement minus the baseline aneurysm measurement.
The measurement obtained from the predischarge CT scan
was considered baseline.
The incidence of maximum aneurysm major diameter
shrinkage of 5 mm, stabilization, and growth of 5 mm
at each examination period through 24months is presented
in Table II for those patients with baseline and follow-up
measurements. The relative change in aneurysm size repre-
sents the percent change from baseline in aneurysm size.
The percent change ([follow-up measurement – baseline
measurement]/baseline measurement)  100. Again, the
measurement obtained from the predischarge CT scan was
considered baseline.
The CT assessment was conducted in a standardized
manner by core lab personnel specifically trained to assess
CT scans for endovascular grafts. All initial measurements
and endoleak assessments by the core lab personnel were
verified by at least one medical reviewer. The core lab
primary investigator was notified of any discrepancies or
notable radiographic findings such as type I or III endoleak.
A linear regression model was used to assess predictive
factors for absolute or relative aneurysm size change at
specific time points of 1, 6, 12, and 24 months. The
predictive variables (covariates) used in this analysis were
endoleak by type12 at the exam period of interest, age,
gender, smoking status; preprocedure variables of maxi-
mum aneurysm major diameter, minor neck diameter,
proximal neck length, neck plaque/thrombus, and neck
shape; and patent inferior mesenteric artery at predischarge.
The frequencies or mean values  SD for each of the
covariates used in the model are presented in Table III.
Preprocedure neck plaque/thrombus was categorized as
no thrombus or thrombus. Preprocedure neck shape was
defined as parallel, irregular, funnel, or inverted funnel. The
core lab assessed each patient’s preoperative CT scan for the
extent of thrombus (pictorial was provided) and neck clas-
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decrease), irregular, or inverted funnel (3-mm increase).
Patients indicated their smoking status as never smoked,
quit previously, or currently smoking. In the presence of
a significant covariate that consisted of multiple levels
(eg, neck shape, smoking status, or endoleak type) a
Bonferroni post hoc analysis was performed to determine
which level(s) of the factor contributed to the overall
significance.
To be included in one or more of the linear regression
analyses, the patient was required to have the predischarge
core lab measurement for aneurysm size, at least one of the
follow-up measurements at 1, 6, 12, or 24 months, and all
Table II. Aneurysm size change (shrinkage, stabilized or
1 month 6
No growth 98.4 (299/304) 99.3
Shrinkage 5 mm 2.3 (7/304) 39.2
Stabilized 96.1 (292/304) 60.1
Growth 5 mm 1.6 (5/304) 0.7
Data are expressed in percentages, with ratios in parenthesis.
Table III. Frequencies or means of the predictive factors
(covariates) included in the linear regression model
Factors
Frequencies in % (ratios)
or mean  SD
Gender
Male 93 (326/351)
Female 7 (25/351)
Age (n  351) 73  8
Preprocedure measurements (mm)
Neck diameter (n  346) 24.5  2.7
Neck length (n  346) 32.0  15.4
Maximum aneurysm major
diameter (n  346) 56.8  8.7
Neck shape
Parallel 83 (291/349)
Irregular 9 (30/349)
Inverted funnel 7 (23/349)
Funnel 1 (5/349)
Neck thrombus/plaque
No thrombus 24 (82/345)
Thrombus 76 (263/345)
Smoking status
Never 13 (45/338)
Quit 68 (229/338)
Current 19 (64/338)
Patent IMA at predischarge
Yes 67 (223/332)
No 33 (109/332)
Endoleak*
Predischarge 14 (37/257)
1 month 10 (27/268)
6 months 9 (26/277)
12 months 8 (21/257)
24 months 7 (16/214)
IMA, Inferior mesenteric artery.
*Includes persistent and new endoleaks of all types.the covariates, which included endoleak assessment at theexam period of interest (1, 6, 12, or 24 months). Any
patient with at least one missing data point was excluded
from the analysis for that particular time point. Thus, of the
351 patients that received the Zenith AAA Endovascular
Graft, 240 patients were available for the analysis at 1
month by having aneurysm size at baseline and 1 month,
endoleak assessment at 1 month, and all additional covari-
ates. Similarly, 242 patients were available for the analysis at
6 months, 226 patients were available for the analysis at 12
months, and 197 patients were available for the analysis at
24 months. Failure to assess for endoleak was the primary
reason a patient was excluded from the analysis. Reasons
for an inability to assess for endoleak included the ab-
sence of a corresponding contrast or noncontrast film,
and film quality.
The linear regression model was used to identify pre-
dictors of aneurysm size change at particular time points;
however, information regarding longitudinal predictors of
aneurysm change was not considered. Amixed linearmodel
was therefore used to perform a longitudinal analysis (using
time as an additional predictor) of the maximum aneurysm
major diameter. A regressionmodel with time as a covariate
assumes that the observations are independent at each time
point; however, when observations are taken within the
same patient over time, this is not the case. A statistical
adjustment of variance is therefore required to account for
the dependency of themeasurements taken within the same
patient over time. This is accomplished via a mixed linear
model, which accounts for the correlation of measurements
taken within patients over time.13 In this analysis, measure-
ments taken from patients at each exam period were con-
sidered simultaneously to assess the overall impact of the
covariates on aneurysm growth/shrinkage over time. Only
those patients with missing covariate data were excluded
from the analysis. Of the 351 patients implanted with the
Zenith AAA Endovascular Graft, 310 patients were in-
cluded in this analysis. The included patients were therefore
required to have at least one postprocedure maximum
aneurysm major diameter measurement and endoleak as-
sessment as well as all remaining covariates.
RESULTS
By linear regression model, none of the independent
variables were predictive of sac size change (absolute or
relative) at 1 month for maximum aneurysm major diame-
ter, minor diameter, or area. At 6, 12, and 24 months,
however, significant predictors of aneurysm size change
th) at each exam period
ths 12 months 24 months
/283) 98.9 (267/270) 97.4 (222/228)
/283) 64.4 (174/270) 69.7 (159/228)
/283) 34.4 (93/270) 27.6 (63/228)
83) 1.1 (3/270) 2.6 (6/228)grow
mon
(281
(111
(170
(2/2were observed. Tables IV, V, and VI present the results
or the
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respectively. These tables include all the covariates consid-
ered in the models and the resulting P values for the
measurements of maximum aneurysm major diameter, mi-
nor diameter, and area. Also included, for all statistically
significant (P .05) covariates, is the estimated effect from
the linear regression model. This effect indicates the mag-
nitude of the difference between the levels of the covariate,
or for continuous covariates, the incremental change in the
outcome variable for every unit increase in the covariate.
This links the statistical significance with clinical relevance.
Results from the linear regression analyses at 6 months
are presented in Table IV. The presence of an endoleak
(P  .01) and preprocedure neck thrombus/plaque
(P  .01) were significant predictors of aneurysm size
change (absolute and relative) for all measurements (major
diameter, minor diameter, and area). These covariates were
more likely to be associated with less sac shrinkage or to
have sac growth as evidenced by the estimated effects
shown in Table IV.
A post hoc analysis was used to detect which endoleak
type was predictive of size change at 6 months. Of the
Table IV. Factors predictive of absolute or relative change
diameter, or area at 6 months
Factor Maj
Age
Absolute
Relative
Preprocedure maximum aneurysm major diameter
Absolute
Relative
Preprocedure neck length
Absolute
Relative
Preprocedure neck minor diameter
Absolute
Relative
Endoleak at 6 months*
Absolute .01 (
Relative .01 (
Gender
Absolute
Relative
Patent inferior mesenteric artery
Absolute
Relative
Preprocedure neck thrombus/plaque
Absolute .01 (
Relative .01 (
Preprocedure neck shape
Absolute
Relative
Smoking status
Absolute
Relative
*The presence of a type II endoleak resulted in significantly less aneurysm
presence of a type III endoleak also resulted in significantly less shrinkage fobserved type II, type III, and type unknown endoleaks at6 months (no type I endoleaks were identified at 6
months), patients with type II endoleaks had significantly
less decrease in absolute or relative size change from pre-
discharge to 6 months than those patients with no en-
doleak. Additionally, the presence of a type III endoleak
resulted in significantly less aneurysm area shrinkage at 6
months compared with patients with no endoleak. Finally,
preoperative maximum aneurysm major diameter was a
significant predictor for absolute change in area (P  .01).
According to the linear regression model, every 1-mm
increase in preoperative maximum aneurysm major diame-
ter is associated with an 11-mm2 decrease in the absolute
change in the area of the maximum aneurysm from baseline
to 6 months.
The significant predictors of size change at 12 months
included preprocedure maximum aneurysm major diame-
ter, the presence of endoleak at 12 months, preoperative
neck thrombus/plaque, and gender (Table V). W i t h t h e
exception of minor diameter relative change, preproce-
dure maximum aneurysm major diameter was a signifi-
cant predictor of aneurysm size change (absolute and
relative) for all measurements (major diameter, minor
he maximum aneurysm major diameter, minimum
P value (estimate of significant effect)
meter Minor diameter Area
.17 .11
.27 .29
.15 .01 (11  3.0)
.61 .59
.41 .5
.31 .4
.86 .77
.98 .97
 1.2) .01 (5.9  1.2) .01 (484  94)
 1.9) .01 (11  2.3) .01 (19  3.5)
.16 .23
.13 .16
.78 .42
.98 .65
 0.8) .01 (2.2  0.8) .01 (179  61)
 1.2) .01 (3.9  1.5) .01 (6.2  2.2)
.38 .23
.52 .43
.34 .31
.37 .26
age for all measurements (Bonferroni post hoc analysis, P  .01), and the
absolute area measurement (Bonferroni post hoc analysis, P  .03).of t
or dia
.29
.49
.2
.76
.63
.63
.95
.84
5.8
9.9
.37
.34
.35
.38
2.1
3.2
.4
.4
.23
.23
shrinkdiameter, and area). The estimates presented in Table V
r diam
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every 1-mm increase in the preprocedure maximum aneu-
rysm major diameter.
Similar to results at 6 months, summarized in Table IV,
the presence of an endoleak at 12 months, specifically type
II as identified from the post hoc analysis, resulted in
significantly less aneurysm shrinkage for all measurements
(estimates are included in Table V). With the exception of
major diameter relative change (P .05), neck thrombus/
plaque was also significant for all measurements. Finally, for
absolute change in maximum aneurysm area at 12 months,
there was a significant difference between men and women
(P  .05). The estimated effect indicates that the absolute
change in maximum aneurysm area for female patients is
less than that of male patients.
At 24 months, significant predictors of aneurysm size
change included preprocedure maximum aneurysm major
diameter, endoleak at 24 months, and preprocedure neck
thrombus/plaque (Table VI). Preprocedure maximum an-
eurysm major diameter was a significant predictor of both
absolute and relative aneurysm size change for all measure-
ments (major diameter, minor diameter, and area). The
Table V. Factors predictive of absolute or relative change
diameter, or area at 12 months
Factor Majo
Age
Absolute
Relative
Preprocedure maximum aneurysm major diameter
Absolute .01 (
Relative .03 (
Preprocedure neck length
Absolute
Relative
Preprocedure neck minor diameter
Absolute
Relative
Endoleak at 12 months*
Absolute .01 (
Relative .01 (
Gender
Absolute
Relative
Patent inferior mesenteric artery
Absolute
Relative
Preprocedure neck thrombus/plaque
Absolute .049 (
Relative
Preprocedure neck shape
Absolute
Relative
Smoking status
Absolute
Relative
*Only the presence of a type II endoleak resulted in significantly less aneurys
except for absolute change and relative change of maximum aneurysm majoestimates listed in Table VI indicate the magnitude of thedecrease at 24 months in aneurysm size for every 1-mm
increase in preprocedure maximum aneurysm major diam-
eter. Similar to the results at 6 and 12 months, a patient
with an endoleak at 24 months, specifically type II as
indicated by the post hoc analysis, experienced less sac
shrinkage or growth. Six patients developed late aneurysm
sac growth of 5 mm at 24 months, all of whom experi-
enced an endoleak, and five of the six patients were identi-
fied with a type II endoleak. The maximum aneurysm
major diameter at each follow-up exam period is plotted in
Fig 1 for each of these six patients, with aneurysm growth
5 mm at 24 months.
The longitudinal model showed that the presence of an
endoleak, thrombus/plaque within the proximal neck at
preprocedure and the preprocedure maximum aneurysm
major diameter were significantly related to the size of the
maximum aneurysm major diameter over time. This result
is consistent with the linear regression analysis discussed
earlier, as these were the primary predictors at each exam
period.
The fitted lines for the presence or absence of an
e maximum aneurysm major diameter, minimum
P value (estimate of significant effect)
eter Minor diameter Area
.22 .5
.27 .69
 0.05) .01 (0.23  0.05) .01 (29  3.7)
 0.08) .08 .049 (0.3  0.1)
.24 .28
.14 .2
.72 .95
.61 .7
1.6) .01 (7.3  1.5) .01 (508  118)
2.6) .01 (13  2.8) .01 (19  4.3)
.08 .048 (264  133)
.13 .08
.89 .63
.97 .72
1.0) .01 (2.4  1.0) .03 (160  74)
.01 (4.4  1.7) .02 (6.5  2.7)
.3 .29
.51 .63
.26 .23
.19 .08
nkage for all measurements (Bonferroni post hoc analysis, adjusted P .01,
eter where the adjusted P  .03 and .02, respectively).of th
r diam
.93
.73
0.23
0.18
.38
.42
.81
.68
5.5 
9.2 
.09
.1
.43
.42
2.0 
.05
.58
.7
.09
.06
m shriendoleak by patient at each of the time points of predis-
rysm s
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shown are 95% confidence bands for the fitted lines. The
slopes of the two fitted lines were found to be significantly
different (P  .01), demonstrating that the rate of aneu-
rysm shrinkage (based on maximum aneurysmmajor diam-
eter) was faster in patients without an endoleak at the time
Fig 1. Six patients demonstrated aneurysm sac growth of5 mm
at 24 months.
Table VI. Factors predictive of absolute or relative change
diameter, or area at 24 months
Factor Majo
Age
Absolute
Relative
Preprocedure maximum aneurysm major diameter
Absolute .01 (
Relative .01 (
Preprocedure neck length
Absolute
Relative
Preprocedure neck minor diameter
Absolute
Relative
Endoleak at 24 months*
Absolute .01 (
Relative .01 (
Gender
Absolute
Relative
Patent inferior mesenteric artery
Absolute
Relative
Preprocedure neck thrombus/plaque
Absolute .046 (
Relative .04 (
Preprocedure neck shape
Absolute
Relative
Smoking status
Absolute
Relative
*Only the presence of a Type II endoleak resulted in significantly less aneupoint compared with those patients with an endoleak.The longitudinal effects of the presence of thrombus/
plaque within the proximal neck before endograft place-
ment on the maximum aneurysm major diameter are pre-
sented in Fig 3. The slopes of the two fitted lines are
he maximum aneurysm major diameter, minimum
P value (estimate of significant effect)
meter Minor diameter Area
.94 .76
.99 .65
 0.07) .01 (0.4  0.07) .01 (41  4.7)
 0.1) .01 (0.3  0.1) .01 (0.5  0.2)
.33 .49
.19 .27
.67 .66
.65 .64
 2.1) .01 (9.7  2.1) .01 (655  150)
3.5) .01 (19  3.8) .01 (28  5.8)
.59 .56
.67 .7
.75 .67
.84 .74
 1.2) .05 .06
 2.1) .04 (4.7  2.2) .03 (7.5  3.5)
.26 .24
.38 .44
.26 .43
.2 .27
hrinkage (Bonferroni post hoc analysis, P  .01).
Fig 2. Graph shows rate of aneurysm shrinkage with or without
an endoleak.of t
r dia
.32
.28
0.3
0.3
.62
.61
.47
.45
7.3
13 
.77
.83
.57
.5
2.5
4.3
.42
.5
.32
.25significantly different (P  .01), with the rate of aneurysm
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within the proximal neck compared with those patients
with thrombus/plaque.
Finally, preprocedure maximum aneurysmmajor diam-
eter (interacted with time) was a significant predictor of
greater shrinkage (P  .01). That is, the rate of aneurysm
shrinkage over time was faster for every unit increase in
preprocedure maximum aneurysm major diameter.
DISCUSSION
The literature has supported the concept that aneu-
rysm sac remodeling, including delayed sac growth or
re-expansion,14 is a device-dependent phenomenon fol-
lowing EVAR. The linear regressionmodel showed that the
three independent variables of preprocedure maximum an-
eurysm major diameter, endoleak, and preprocedure neck
thrombus/plaque were predictive of aneurysm sac size
change following EVAR with the Zenith tri-modular bifur-
cated endograft. Patients with larger preoperative aneu-
rysms had greater aneurysm sac shrinkage. Patients with
type II and type III endoleaks and preprocedure neck
thrombus/plaque had less aneurysm shrinkage.
That endoleaks are associated with pressurization of
the aneurysm sac has been reported previously in the
literature and serves to partially explain the impact on sac
shrinkage and remodeling.15,16 Greenberg et al17 have
demonstrated that endoleaks have a moderating effect on
sac remodeling and shrinkage over time. In addition, this
current study identifies definitive endoleak classifications
that are predictive of aneurysm sac size change. Although
the literature has demonstrated that freedom from en-
doleak is not predictive of freedom from endotension,18 all
cases of sac enlargement in this study cohort were associ-
ated with endoleak, and in particular, type II endoleak.
To our knowledge, the moderating effect of preproce-
dure neck thrombus/plaque on subsequent sac shrinkage
has not been reported previously. Other pivotal trial results
Fig 3. Graph shows rate of aneurysm shrinkage by preoperative
neck quality.have not demonstrated that proximal neck anatomy influ-ences sac remodeling.19 Patients were largely selected for
the Zenith AAA multicenter trial who had favorable aortic
neck anatomy, such that only 6% of the enrolled patients
were categorized by the core lab as having complete or
circumferential preprocedure neck thrombus/plaque. This
report and others may therefore underestimate the impact of
complicated neck anatomy on subsequent sac remodeling.
Achieving seal in a circumferential or complete thrombus-
lined neck may impede sac shrinkage if there is persistent
transmission of pressure across thrombus and into the sac.
Further study is needed to elucidate the mechanism of
reduced sac shrinkage in the presence of preprocedure neck
thrombus/plaque.
A linear mixed model for longitudinal assessment
showed that the rate of aneurysm shrinkage was signifi-
cantly faster in patients with larger aneurysms and without
an endoleak at any time point. In addition, patients with no
neck thrombus/plaque had faster rates of aneurysm shrink-
age than those with partial or complete thrombus/plaque.
This study suggests that the impact of preoperative
aneurysm size, preprocedure neck thrombus/plaque, and
endoleak on early and late sac remodeling may have been
previously underappreciated. Although only six patients
had evidence of aneurysm sac enlargement at 24 months,
there appears to be a potential relationship between sac
growth and the presence of persistent type II endoleak.
Because sac shrinkage developed in some patients over time
in spite of the presence of a persistent type II endoleak,
clearly not all type II endoleaks consistently impact sac
remodeling. It has been demonstrated that in patients with
persistent type II endoleaks, the maximum diameter of the
endoleak cavity (nidus) is a predictor of aneurysm sac
expansion.20 Further analysis is needed to better under-
stand the impact of type II endoleak in the Zenith clinical
study.
A number of study limitations should be recognized.
These include missing data points, retrospective analysis,
and other potentially important variables not considered
such as iliac diameters, proximal and distal fixation lengths,
and specific quantification of neck plaque/thrombus.
The influence of baseline AAA diameter on subsequent
aneurysm sac shrinkage has been previously reported.17
Alternatively, other reports have been unable to demon-
strate differences in sac shrinkage out to 24 months be-
tween large and small aneurysms.21
The data presented herein strongly support the concept
that patients with larger preoperative aneurysms had
greater and more rapid aneurysm sac shrinkage. This was
true when viewed from the perspective of both absolute
and relative (percent) change in major diameter, minor
diameter, and area.
These data may be used to provide standards for ex-
pected sac behavior following EVAR using the Zenith
endograft but cannot be generalized for other endograft
designs. Similarly, this model is not predictive of sac behav-
ior when the Zenith endograft is placed in patients who are
outside of the anatomic inclusion criteria that were man-
dated for the clinical trial. Sac remodeling that is inconsis-
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tri-modular endograft should raise concern and lead to
further investigation and closer surveillance.
It is intuitively sound to advocate treatment of type II
endoleak in the presence of aneurysm growth. In addition,
when a type unknown endoleak is associated with sac
growth, angiographic assessment to define the endoleak
with subsequent treatment is warranted. This study does
not identify variables predictive of less favorable outcomes
after EVAR, nor do the findings of this report provide
information that should influence patient selection.
Although considerable enthusiasm has been generated
recently over the sensitivity of aneurysm sac volume mea-
surements in the postoperative period,22,23 this study dem-
onstrates rather dynamic changes in the aneurysm sac using
what some might view as traditional measuring tools. The
area and major/minor diameter calculations were clearly
reflective of aneurysm sac size change. Furthermore, these
changes in the aneurysm sac were detectable as early as 6
months after implant.
It would be interesting to also analyze these findings in
the context of volume measurements; however, many of
the CT scans submitted to the core laboratory did not
provide enough information to accurately calculate vol-
ume. That being said, newer computer software has simpli-
fied the acquisition of diameter and volume data for the
practicing endovascular surgeon in clinical practice.24 The
analysis of baseline and serial follow-up diameter/volume
data is now within reach of every practicing vascular sur-
geon; it no longer resides only in the radiology department.
CONCLUSIONS
This study supports the concept that although sac
remodeling after EVAR is a complex phenomenon, early
and late sac size change is clearly influenced by identifiable,
independent, predictive variables.
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